Eribulin: a new treatment option in metastatic breast cancer heavily pretreated?

被引：0
|
作者：
Goncalves, Anthony
机构：
来源：
BULLETIN DU CANCER | 2011年 / 98卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [41] Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: A multicenter retrospective study.
    Zhao, Yannan
    Xie, Ning
    Li, Wei
    Chen, Wenyan
    Lv, Zheng
    Zheng, Yabing
    Sun, Tao
    Liu, Jieqiong
    Zhang, Jian
    Hu, Shihui
    Wang, Yajun
    Gong, C. C.
    Li, Yi
    Xie, Yizhao
    Ge, Rui
    Xu, Fei
    Wang, Biyun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study (vol 94, pg 10, 2018)
    Pedersini
    ONCOLOGY, 2018, 95 (06) : 380 - 380
  • [43] Activity of eribulin mesylate in heavily pretreated breast cancer granted access via the Cancer Drugs Fund
    Ramaswami, Ramya
    O'Cathail, Sean M.
    Brindley, James H.
    Silcocks, Paul
    Mahmoud, Sarah
    Palmieri, Carlo
    FUTURE ONCOLOGY, 2014, 10 (03) : 363 - 376
  • [44] What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?
    Verma, S
    Trudeau, M
    Dranitsaris, G
    Clemons, M
    Joy, AA
    MacKey, JR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6260 - 6260
  • [45] Fulvestrant in heavily pretreated metastatic breast cancer: Is it still effective as a very advanced line of treatment?
    Safra, Tamar
    Greenberg, Julia
    Ron, Ilan G.
    Ben-Yosef, Rami
    Inbar, Moshe
    Sarid, David
    Yaal-Hahoshen, Neora
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (05): : 339 - 343
  • [46] Everolimus in combination with carboplatin: a promising treatment with low toxicity in heavily pretreated metastatic breast cancer
    Schwarzlose-Schwarck, S.
    Regierer, A. C.
    Martus, P.
    Schulz, C. -O.
    Liu, H.
    Schefe, J. H.
    Possinger, K.
    Scholz, C. W.
    Eucker, J.
    ONKOLOGIE, 2011, 34 : 118 - 118
  • [47] Response to eribulin in a difficult-to-treat, heavily pretreated breast cancer patient: a case report
    Leo, Luigi
    Caputo, Francesca
    Di Sarno, Antonella
    Garofano, Tiziana
    Andreozzi, Francesca
    Massaro, Maria Grazia
    Montesarchio, Vincenzo
    FUTURE ONCOLOGY, 2015, 11 (15) : 27 - 30
  • [48] Clinical benefit of fulvestrant in heavily pretreated patients with metastatic breast cancer
    Scandurra, Giuseppa
    Carillio, Guido
    Aiello, Rosa Anna
    Chiarenza, Maurizio
    Mazzola, Antonella
    Ali, Marco
    Barone, Gloria
    Greco, Filippo
    Caruso, Michele
    ANNALS OF ONCOLOGY, 2007, 18 : 44 - 44
  • [49] Metronomic capecitabine in heavily pretreated metastatic triple negative breast cancer
    El-Sadda, W. M.
    CANCER RESEARCH, 2017, 77
  • [50] Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer
    Sun Young Rha
    Yong Hwa Moon
    Hei Chul Jeung
    Yong Tae Kim
    Joo Hyuk Sohn
    Woo Ick Yang
    Chang Ok Suh
    Gwi Eon Kim
    Jae Kyung Roh
    Hyun Cheol Chung
    Breast Cancer Research and Treatment, 2005, 90 : 215 - 221
12345